Your browser doesn't support javascript.
loading
Misfolded GBA/ß-glucocerebrosidase impairs ER-quality control by chaperone-mediated autophagy in Parkinson disease.
Kuo, Sheng-Han; Tasset, Inmaculada; Cuervo, Ana Maria; Sulzer, David.
Afiliação
  • Kuo SH; Department of Neurology, Columbia University, New York, NY, USA.
  • Tasset I; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, New York, NY, USA.
  • Cuervo AM; Institute for Aging Studies, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Sulzer D; Department of Biochemistry and Molecular Biology, University of Córdoba, Córdoba, Spain.
Autophagy ; 18(12): 3050-3052, 2022 12.
Article em En | MEDLINE | ID: mdl-35482760
ABSTRACT
Inhibition of chaperone-mediated autophagy (CMA), a selective type of lysosomal degradation for intracellular proteins, may contribute to pathogenesis in neurodegenerative diseases including Parkinson disease (PD). Pathogenic variants of PD-related proteins that reside in the cytosol, including SNCA/alpha-synuclein, LRRK2 (leucine rich repeat kinase 2), UCHL1 (ubiquitin Cterminal hydrolase 1) and VPS35 (VPS35 retromer complex component), exert inhibitory effects on CMA. Decreased CMA activity has also been reported in sporadic PD patients, consistent with an association between CMA inhibition and PD. We have now reported the first example of CMA dysfunction caused by a non-cytosolic PD-related protein, GBA/ß-glucocerebrosidase, the most common genetic risk factor for PD, which uncovers a new role for CMA in endoplasmic reticulum (ER) quality control.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Autofagia Mediada por Chaperonas / Glucosilceramidase Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Autofagia Mediada por Chaperonas / Glucosilceramidase Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article